BMS-582949   

GtoPdb Ligand ID: 7838

Synonyms: BMS 582949 | BMS582949 | PS 540446 | PS-540446 | PS540446
Compound class: Synthetic organic
Comment: BMS-582949 is an inhibitor of p38 mitogen-activated protein kinase (MAPK). Its discovery is described in [1].
2D Structure
Click here for structure editor
Physico-chemical Properties
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 9
Topological polar surface area 100.42
Molecular weight 406.21
XLogP 3.46
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Canonical SMILES CCCNC(=O)c1cn2c(c1C)c(ncn2)Nc1cc(ccc1C)C(=O)NC1CC1
Isomeric SMILES CCCNC(=O)c1cn2c(c1C)c(ncn2)Nc1cc(ccc1C)C(=O)NC1CC1
InChI InChI=1S/C22H26N6O2/c1-4-9-23-22(30)17-11-28-19(14(17)3)20(24-12-25-28)27-18-10-15(6-5-13(18)2)21(29)26-16-7-8-16/h5-6,10-12,16H,4,7-9H2,1-3H3,(H,23,30)(H,26,29)(H,24,25,27)
InChI Key GDTQLZHHDRRBEB-UHFFFAOYSA-N
No information available.
Summary of Clinical Use
BMS-582949 was assessed in Phase II clinical trials for atherosclerosis (NCT00570752) and rheumatoid arthritis (NCT00605735). There are no currently active trials for this compound (Nov 2014).